ArticleCurrent oncology (Toronto, Ont.)2023

Adjuvant ICIs Plus Targeted Therapies Reduce HCC Recurrence after Hepatectomy in Patients with High Risk of Recurrence.

Jianming Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.